Loading
Skip to content
Miracle Minds AI
  • Try “HIPAA”, “model risk”, “FinOps” or “agentic”.

AI for Life Sciences & Healthcare

Drug and device makers, hospitals, health systems and payers need AI that clinicians trust and quality and compliance teams can approve. For providers and payers we deliver clinical decision support, care operations and revenue-cycle AI. For life sciences companies we deliver AI for clinical trials, drug safety, manufacturing quality and AI-enabled devices. All of it comes with the validation, privacy and record-keeping the sector requires, and we stay to monitor it in use.

A clean, brightly lit hospital corridor

Where AI pays off in life sciences & healthcare.

8 focus areas. Each has a sourced brief: what decides whether it pays off, the rules that apply, where it goes wrong and how to measure it.

One team for life sciences & healthcare, across every practice.

Most engagements start with a senior advisor inside your leadership team. Each practice then fields a team built for this sector.

Clinical AI validation, validated and auditable records, and HIPAA-aligned privacy and security assurance.

Every engagement in this sector is scoped against the rules that apply to it, and the evidence is produced as the work happens rather than assembled afterwards.

Offerings most used here

Rules we scope against

  • HIPAA
  • FDA 21 CFR Part 11 electronic records and signatures
  • ICH E6(R3) Good Clinical Practice
  • 21 CFR 314.80 safety reporting
  • FDA Quality Management System Regulation (21 CFR Part 820)
  • EU GMP Annex 22 on AI (draft)
  • FDA Clinical Decision Support guidance (2026)
  • HHS Section 1557 nondiscrimination
  • CMS prior authorization rule (CMS-0057-F)
  • ONC HTI-5 (decision support transparency removed from Dec 2026)
  • TCPA for patient outreach